Cargando…
Importance of beta-lactam pharmacokinetics and pharmacodynamics on the recovery of microbial diversity in the airway of persons with cystic fibrosis
Cystic fibrosis (CF) is a chronic lung disease characterized by acute pulmonary exacerbations (PExs) that are frequently treated with antibiotics. The impact of antibiotics on airway microbial diversity remains a critical knowledge gap. We sought to define the association between beta-lactam pharmac...
Autores principales: | Hahn, Andrea, Burrell, Aszia, Chaney, Hollis, Sami, Iman, Koumbourlis, Anastassios C, Freishtat, Robert J, Zemanick, Edith T, Louie, Stan, Crandall, Keith A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485129/ https://www.ncbi.nlm.nih.gov/pubmed/34021052 http://dx.doi.org/10.1136/jim-2021-001824 |
Ejemplares similares
-
Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosis
por: Hahn, Andrea, et al.
Publicado: (2023) -
Using metabolic potential within the airway microbiome as predictors of clinical state in persons with cystic fibrosis
por: Shumyatsky, Gabriella, et al.
Publicado: (2023) -
Impact of Antibiotics on the Lung Microbiome and Lung Function in Children With Cystic Fibrosis 1 Year After Hospitalization for an Initial Pulmonary Exacerbation
por: Inam, Zaina, et al.
Publicado: (2022) -
Antibiotic multidrug resistance in the cystic fibrosis airway microbiome is associated with decreased diversity
por: Hahn, Andrea, et al.
Publicado: (2018) -
Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation
por: Hahn, Andrea, et al.
Publicado: (2020)